389 related articles for article (PubMed ID: 28632749)
1. Using a health-rating system to evaluate the usefulness of Caenorhabditis elegans as a model for anthelmintic study.
Weaver KJ; May CJ; Ellis BL
PLoS One; 2017; 12(6):e0179376. PubMed ID: 28632749
[TBL] [Abstract][Full Text] [Related]
2. An extensive comparison of the effect of anthelmintic classes on diverse nematodes.
Hu Y; Ellis BL; Yiu YY; Miller MM; Urban JF; Shi LZ; Aroian RV
PLoS One; 2013; 8(7):e70702. PubMed ID: 23869246
[TBL] [Abstract][Full Text] [Related]
3. Nitazoxanide: nematicidal mode of action and drug combination studies.
Somvanshi VS; Ellis BL; Hu Y; Aroian RV
Mol Biochem Parasitol; 2014 Jan; 193(1):1-8. PubMed ID: 24412397
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of albendazole plus ivermectin, albendazole plus mebendazole, albendazole plus oxantel pamoate, and mebendazole alone against Trichuris trichiura and concomitant soil-transmitted helminth infections: a four-arm, randomised controlled trial.
Speich B; Ali SM; Ame SM; Bogoch II; Alles R; Huwyler J; Albonico M; Hattendorf J; Utzinger J; Keiser J
Lancet Infect Dis; 2015 Mar; 15(3):277-84. PubMed ID: 25589326
[TBL] [Abstract][Full Text] [Related]
5. Activity of novel nicotinic anthelmintics in cut preparations of Caenorhabditis elegans.
Ruiz-Lancheros E; Viau C; Walter TN; Francis A; Geary TG
Int J Parasitol; 2011 Mar; 41(3-4):455-61. PubMed ID: 21195075
[TBL] [Abstract][Full Text] [Related]
6. The sensory amphidial structures of Caenorhabditis elegans are involved in macrocyclic lactone uptake and anthelmintic resistance.
Page AP
Int J Parasitol; 2018 Nov; 48(13):1035-1042. PubMed ID: 30253131
[TBL] [Abstract][Full Text] [Related]
7. Molecular aspects of drug resistance in parasitic helminths.
Roos MH; Kwa MS; Veenstra JG; Kooyman FN; Boersema JH
Pharmacol Ther; 1993 Nov; 60(2):331-6. PubMed ID: 8022863
[TBL] [Abstract][Full Text] [Related]
8. Phytochemical analysis and in vitro anthelmintic activity of Lophira lanceolata (Ochnaceae) on the bovine parasite Onchocerca ochengi and on drug resistant strains of the free-living nematode Caenorhabditis elegans.
Kalmobé J; Ndjonka D; Boursou D; Vildina JD; Liebau E
BMC Complement Altern Med; 2017 Aug; 17(1):404. PubMed ID: 28806951
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of recommended drugs against soil transmitted helminths: systematic review and network meta-analysis.
Moser W; Schindler C; Keiser J
BMJ; 2017 Sep; 358():j4307. PubMed ID: 28947636
[No Abstract] [Full Text] [Related]
10. Anthelmintic drugs and nematicides: studies in Caenorhabditis elegans.
Holden-Dye L; Walker RJ
WormBook; 2014 Dec; ():1-29. PubMed ID: 25517625
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an FDA approved library against laboratory models of human intestinal nematode infections.
Keiser J; Panic G; Adelfio R; Cowan N; Vargas M; Scandale I
Parasit Vectors; 2016 Jul; 9(1):376. PubMed ID: 27363703
[TBL] [Abstract][Full Text] [Related]
12. Drug Combinations Against Soil-Transmitted Helminth Infections.
Moser W; Schindler C; Keiser J
Adv Parasitol; 2019; 103():91-115. PubMed ID: 30878060
[TBL] [Abstract][Full Text] [Related]
13. Anthelmintic activity of KSI-4088 against Caenorhabditis elegans.
Kaewintajuk K; Cho PY; Kim SY; Lee ES; Lee HK; Choi EB; Park H
Parasitol Res; 2010 Jun; 107(1):27-30. PubMed ID: 20309581
[TBL] [Abstract][Full Text] [Related]
14. An in vitro larval motility assay to determine anthelmintic sensitivity for human hookworm and Strongyloides species.
Kotze AC; Clifford S; O'Grady J; Behnke JM; McCarthy JS
Am J Trop Med Hyg; 2004 Nov; 71(5):608-16. PubMed ID: 15569793
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the xenobiotic response of Caenorhabditis elegans to the anthelmintic drug albendazole and the identification of novel drug glucoside metabolites.
Laing ST; Ivens A; Laing R; Ravikumar S; Butler V; Woods DJ; Gilleard JS
Biochem J; 2010 Dec; 432(3):505-14. PubMed ID: 20929438
[TBL] [Abstract][Full Text] [Related]
16. Anogeissus leiocarpus extract on the parasite nematode Onchocerca ochengi and on drug resistant mutant strains of the free-living nematode Caenorhabditis elegans.
Ndjonka D; Ajonina-Ekoti I; Djafsia B; Lüersen K; Abladam E; Liebau E
Vet Parasitol; 2012 Nov; 190(1-2):136-42. PubMed ID: 22727616
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity to ivermectin and pyrantel of Ancylostoma ceylanicum and Necator americanus.
Behnke JM; Rose R; Garside P
Int J Parasitol; 1993 Nov; 23(7):945-52. PubMed ID: 8106187
[TBL] [Abstract][Full Text] [Related]
18. Interactions of anthelmintic drugs in Caenorhabditis elegans neuro-muscular ion channel mutants.
Miltsch SM; Krücken J; Demeler J; Ramünke S; Harder A; von Samson-Himmelstjerna G
Parasitol Int; 2013 Dec; 62(6):591-8. PubMed ID: 23707730
[TBL] [Abstract][Full Text] [Related]
19. Quantifying the fitness effects of resistance alleles with and without anthelmintic selection pressure using Caenorhabditis elegans.
Shaver AO; Miller IR; Schaye ES; Moya ND; Collins JB; Wit J; Blanco AH; Shao FM; Andersen EJ; Khan SA; Paredes G; Andersen EC
PLoS Pathog; 2024 May; 20(5):e1012245. PubMed ID: 38768235
[TBL] [Abstract][Full Text] [Related]
20. Anthelmintic drug actions in resistant and susceptible C. elegans revealed by electrophysiological recordings in a multichannel microfluidic device.
Weeks JC; Robinson KJ; Lockery SR; Roberts WM
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):607-628. PubMed ID: 30503202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]